Clinical-spectrum validation as the next step for cfRNA-based preoperative risk stratification of myometrial masses (Reply to Letter-to-the-Editor)

Aymara Mas, Sören R. Stahlschmidt, Carlos Simón

Open source

DOI
10.1016/j.ajog.2026.09.014
Published
2026-09
Container
American Journal of Obstetrics and Gynecology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ajog.2026.09.014,
  title = {Clinical-spectrum validation as the next step for cfRNA-based preoperative risk stratification of myometrial masses (Reply to Letter-to-the-Editor)},
  author = {Aymara Mas and Sören R. Stahlschmidt and Carlos Simón},
  year = {2026},
  journal = {American Journal of Obstetrics and Gynecology},
  doi = {10.1016/j.ajog.2026.09.014},
  url = {https://doi.org/10.1016/j.ajog.2026.09.014}
}

RIS

TY  - JOUR
TI  - Clinical-spectrum validation as the next step for cfRNA-based preoperative risk stratification of myometrial masses (Reply to Letter-to-the-Editor)
AU  - Aymara Mas
AU  - Sören R. Stahlschmidt
AU  - Carlos Simón
PY  - 2026
JO  - American Journal of Obstetrics and Gynecology
DO  - 10.1016/j.ajog.2026.09.014
UR  - https://doi.org/10.1016/j.ajog.2026.09.014
ER  - 

APA

Mas, A., Stahlschmidt, S. R., & Simón, C. (2026). Clinical-spectrum validation as the next step for cfRNA-based preoperative risk stratification of myometrial masses (Reply to Letter-to-the-Editor). American Journal of Obstetrics and Gynecology. https://doi.org/10.1016/j.ajog.2026.09.014

Source records